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Mice Lacking a-Synuclein Display Functional
Deficits in the Nigrostriatal Dopamine System
of the adult central nervous system (CNS) that display
synaptic plasticity, including the cerebral cortex, hippo-
campus, amygdala, and olfactory bulb (Maroteaux and
Asa Abeliovich,1,7 Yvonne Schmitz,4,7 Isabel FarinÄ as,2,7
Derek Choi-Lundberg,3,7 Wei-Hsien Ho,3
Pablo E. Castillo,5 Natasha Shinsky,3
Scheller, 1991; Iwai et al., 1995). The zebra finch a-SynJose Manuel Garcia Verdugo,2 Mark Armanini,3
homolog synelfin has also been implicated in synapticAnne Ryan,3 Mary Hynes,3 Heidi Phillips,3
plasticity since it is expressed in the lateral magnocellu-David Sulzer,4 and Arnon Rosenthal3,6
lar nucleus, a brain area that participates in seasonal1Department of Neurology
song learning (George et al., 1995).University of California, San Francisco
a-Syn belongs to a family of structurally related pro-San Francisco, California 94143
teins that are prominently expressed in the CNS and2Department BiologõÂa Celular
includes b-Syn and g-Syn (Jakes et al., 1994; BuchmanUniversidad de Valencia
et al., 1998; Lavedan, 1998). The subcellular localization46100 Burjasot
of the synucleins has not been established definitively,Spain
and suggested sites of action include the presynaptic3Department of Neuroscience
terminal, the nuclear envelope, and the cytoplasm (Maro-Genentech
teaux and Scheller, 1991; Iwai et al., 1995; Lavedan,South San Francisco, California 94080
1998). The synucleins all possess a highly conserved4Departments of Neurology and Psychiatry
amino-terminal repeat domain that may mediate bothColumbia University
lipid binding and dimerization (Jensen et al., 1997). InNew York State Psychiatric Institute
addition, they share a common ªnatively unfoldedº ter-Department of Neuroscience
tiary structure that has been implicated in protein±New York, New York 10032
protein interactions (Weinreb et al., 1996; Davidson et al.,5Nancy Friend Pritzker Laboratory
1998). Reported binding targets for a-Syn and b-SynDepartments of Psychiatry
include phospholipase D2 (PLD2; Jenco et al., 1998), anand Behavioral Sciences
enzyme that catalyzes the production of the intracellularStanford University School of Medicine
mediators phosphatidic acid (PA) and diacylglycerolPalo Alto, California 94304
(DAG) (Klein et al., 1995; Jenco et al., 1998), and protein
kinase C (Ostrerova et al., 1999).
Although its physiological activity remains unclear,Summary
a-Syn has been implicated in the etiology of two com-
mon neurodegenerative disorders, Alzheimer's disease
a-Synuclein (a-Syn) is a 14 kDa protein of unknown
(AD) and Parkinson's disease (PD). The pathological
function that has been implicated in the pathophysiol- hallmark of AD involves widespread depositions (termed
ogy of Parkinson's disease (PD). Here, we show that amyloid plaques) of a 42 amino acid b-amyloid peptide
a-Syn2/2 mice are viable and fertile, exhibit intact brain (Ab) concomitant with the degeneration of hippocampal
architecture, and possess a normal complement of and cortical neurons. The cause of Ab depositions is
dopaminergic cell bodies, fibers, and synapses. Nigro- not fully understood. However, a fragment of a-Syn
striatal terminals of a-Syn2/2 mice display a standard termed the nonamyloid component (NAC; Ueda et al.,
pattern of dopamine (DA) discharge and reuptake in 1993) was found to be an integral constituent of these
response to simple electrical stimulation. However, plaques in the AD brain. Moreover, NAC binds to
they exhibit an increased release with paired stimuli b-amyloid peptide in vitro and facilitates its aggregation
that can be mimicked by elevated Ca21. Concurrent (Jensen et al., 1995, 1997; Paik et al., 1998), raising the
with the altered DA release, a-Syn2/2 mice display a possibility that NAC facilitates plaque formation and the
reduction in striatal DA and an attenuation of DA- progression of AD.
dependent locomotor response to amphetamine. These PD brain pathology is typified by the presence of ab-
findings support the hypothesis that a-Syn is an essen- normal protein aggregates, termed Lewy bodies, and
tial presynaptic, activity-dependent negative regulator selective loss of dopamine (DA) neurons. a-Syn appears
of DA neurotransmission. to be the major protein component of these intracy-
toplasmic deposits in sporadic and familial forms of the
disease (Mezey et al., 1998; Spillantini et al., 1998). Direct
Introduction evidence for the involvement of a-Syn in PD was pro-
vided by genetic studies of patients with rare, domi-
a-Synuclein (a-Syn) was initially isolated from choliner- nantly inherited variants of this disorder. Two indepen-
gic nerve terminals of the Torpedo ray electric organ dent pathological mutations have been described, a
(Maroteaux et al., 1988). Mammalian a-Syn was subse- change from alanine to threonine at position 53 in Italian-
quently found to be prominently expressed in regions American and Greek families (Polymeropoulos et al.,
1997) and a change from alanine to proline at position
30 in a family of German origin (KruÈ ger et al., 1998).6 To whom correspondence should be addressed (e-mail: ar@ruby.
These mutant proteins display a propensity to form Lewygene.com).
7 These authors contributed equally to this work. body±like fibrils in vitro (Conway et al., 1998).
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Given the evidence that a-Syn plays a role in PD and 2D). This protein was completely absent from the stria-
tum of the a-Syn2/2 mice (Figure 2D). In contrast, axonsAD, we undertook to determine its normal function by
the analysis of a-Syn-deficient mice. a-Syn2/2 mice are in the striatum were immunopositive for b-Syn both in
wt and a-Syn2/2 mice (Figure 4C).viable; possess a wild-type (wt) complement of DA neu-
rons, fibers and synaptic terminals; and reveal a normal
time course of DA release and reuptake in response to a
a-Syn Is Not Essential for Neuronal Developmentsingle electrical pulse stimulus of nigrostriatal terminals.
or for the Formation of Presynaptic TerminalsSurprisingly, the mutant mice exhibit accelerated recov-
Given the finding that human a-Syn mutations lead toery of DA release when presented with multiple stimuli.
the degeneration of DA neurons in the ventral midbrain,Similar accelerated recovery is observed in wt animals
we examined the status of this neuronal population inin the presence of increased extracellular Ca21. The
the a-Syn2/2 mice. Surprisingly, 3- to 6-week-old a-Syn2/2
a-Syn2/2 mice also suffer a reduction in total striatal
animals possess a typical complement of tyrosine hy-DA and display an attenuated locomotor response to
droxylase positive (TH1) midbrain DA neurons in theamphetamine. These findings support the idea that
SN (midbrain DA neuronal counts from alternating sec-
a-Syn is an essential, activity-dependent negative regu-
tions through the SN: wt, 3273 6 15, n 5 3; a-Syn2/2,lator of DA neurotransmission that may modulate a pro-
3396 6 52, n 5 3; Figure 3A). Moreover, the DA neuronscess requiring Ca21.
appear morphologically indistinguishable from wt (Fig-
ure 3B), and the density of DA projections to the striatum
Results (the nigrostriatal pathway; Figure 3C) is normal. In addi-
tion, neurons and support cells in the striatum itself
Generation of a-Syn2/2 Mice appear unaltered, as determined by the number and
An a-Syn gene-targeting construct was generated in morphology of cells positive for neuropeptide Y, so-
which the first two exons, encoding amino acids 1±41 matostatin, parvalbumin, calretinin, TrkA, g-aminobu-
and upstream untranslated sequences, were deleted tyric acid (GABA), and glial fibrillary acid protein (Figure
(Figure 1A). This targeting construct was electroporated 3D; data not shown). The general striatal matrix architec-
into embryonic stem (ES) cells, and three independent ture, as indicated by calbindin staining, is also preserved
clones in which a-Syn had been disrupted by homolo- in mutant mice. Finally, the a-Syn2/2 mice do not display
gous recombination were injected into blastocysts to any gross morphological deficits in midbrain, striatum,
produce a-Syn2/2 mice (Figures 1B and 1C). The result- cerebellum, basal forebrain, hippocampus, or cerebral
ing heterozygous (a-Syn1/2) and homozygous (a-Syn2/2) cortex, as determined by toluidine blue staining (data
mice were viable, normal in size, and fertile and did not not shown), indicating that a-Syn is not required for
display any gross anatomical abnormalities (data not neuronal development and differentiation.
shown). To determine whether the a-Syn gene had in- As a-Syn has been hypothesized to function in vesicu-
deed been inactivated, expression of a-Syn mRNA was lar neurotransmitter release (Clayton and George, 1998),
analyzed by RT-PCR using primers specific for either we next investigated whether its absence would alter
the deleted 59 terminus (encoding amino acids 1±92) the expression and distribution of well-characterized
or the remaining 39 sequences (encoding amino acids synaptic vesicle proteins (SuÈ dhof, 1995). To this aim,
76±136) of the gene. No transcripts derived either from brain sections from a-Syn2/2 and wt mice were immuno-
the 59 or 39 regions of a-Syn were detected in the brains stained with antibodies specific for the proteins Rab3a,
of the mutant mice (Figure 1D), confirming that the a-Syn synapsin-I, synaptophysin, and b-Syn. The distribution
gene is no longer functional. Western blot analysis of of these proteins appears to be unaltered in the mutant
brain homogenates with an antibody specific to the car- mice, suggesting that the loss of a-Syn does not lead to
boxyl terminus of a-Syn further demonstrated the ab- gross alterations in the protein composition of synaptic
sence of a-Syn protein in these mice (Figure 1E). In terminals (Figures 4A±4C; data not shown). We further
contrast, no changes in the levels of b-Syn and g-Syn employed electron microscopy to determine whether
transcripts or protein were detected (Figures 1D and 1E). the absence of a-Syn leads to changes in synaptic den-
In situ hybridization analyses further revealed promi- sity or structural aberrations in synaptic terminals. The
nent expression a-Syn in the cerebral cortex, hippocam- synaptic density in the striatum of the Syn2/2 mice was
pus, striatum, and ventral midbrain of wt mice (Figure indistinguishable from that of wt littermates (wt, 18.7 6
2A). In contrast, b-Syn expression appeared to be rela- 0.4 synapses/100 mm2, n 5 3; Syn2/2, 19.2 6 0.9 syn-
tively widespread in the adult CNS (Figure 2B), whereas apses/100 mm2, n 5 3). Furthermore, presynaptic dense
g-Syn was principally restricted to the DA neurons of projections, postsynaptic densities, and synaptic vesi-
the substantia nigra (SN) and ventral tegmental area cles all appear normal in morphology and distribution
(VTA; Figure 2C; Lavedan, 1998). a-Syn transcripts were throughout the striatum and hippocampus of the a-Syn2/2
absent from the a-Syn2/2 mice (Figure 2A), whereas the mice, when compared with wt siblings (Figure 4D; data
expression patterns for b-Syn and g-Syn mRNA ap- not shown). Thus, a-Syn may not be an essential struc-
peared normal (Figures 2B and 2C), indicating that the tural component of presynaptic terminals.
absence of a-Syn had not been compensated for by
changes in the tissue distribution or levels of other sy-
nuclein family members. Antibody staining for a-Syn a-Syn Is Not Essential for Release and Reuptake
at Dopaminergic Terminalsprotein in the striatum of wt animals reveals a character-
istic punctate distribution, consistent with the accumu- As a-Syn is prominently expressed at the nerve termi-
nals of nigral DA neurons and, when mutated, can causelation of this protein in axons (but not cell bodies; Figure
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Figure 1. Generation of a-Syn2/2 Mice
(A) The a-Syn targeting vector, wt allele, and
mutated allele. The first two exons, encoding
amino acids 1±41, are missing from the mu-
tated allele. The location of the probe used
in Southern blots is indicated (probe); the
neomycin resistance gene, driven by the phos-
phoglycerate-1 promoter, is marked (PGK-
neo); the striped and solid boxes represent
noncoding and coding sequences of the first
two exons, respectively. The directions of
gene transcription for PGK-neo and a-Syn are
indicated by horizontal solid arrows. Primers
(ªa±dº) were used for PCR amplification in (C).
(B and C) Genotype analyses of tail DNA from
wt (1/1), heterozygous mutant (1/2), and
homozygous mutant (2/2) mice by Southern
blotting (B) and by PCR amplification (C).
(D) RT-PCR analyses of cerebral cortex RNA
with primers specific for a-Syn 59 sequences
that cover the disrupted exons, a-Syn 39 se-
quences, or b-Syn.
(E) Western blot analyses of a-Syn and b-Syn
protein.
their degeneration, we sought to examine whether it The time course of measured extracellular DA, in re-
sponse to either a single electrical stimulus or a train ofmight regulate synaptic function in the nigrostriatal path-
way. Striatal slice preparations containing presynaptic stimuli, appeared normal in a-Syn2/2 mice, indicating
that DA reuptake and diffusion are unaltered (data notDA terminals were stimulated by a single electrical pulse
(400 mA, 1 ms) or a train of 10 such pulses at 50 ms shown). Similarly, the peak concentration of extracellu-
lar DA, in response to either a single electrical pulse orintervals (20 Hz), which approximates the observed
ªburst firingº pattern of nigral DA neurons in vivo (Grace a train of pulses, did not differ significantly between
slice preparations from wt and Syn2/2 mice (p . 0.05and Bunney, 1984). Following stimulation, the concen-
tration and kinetics of DA release were measured using for each, two-sample Student's t test; Figure 5C). Taken
together, these findings indicate that a-Syn is not in-fast-scan cyclic voltammetry (CV; Figure 5A; Wightman
and Zimmerman, 1990; Kennedy et al., 1992). In re- volved in the control of DA release in response to simple
single or train stimuli.sponse to electrical stimulation, a rapid rise in the level
of extracellular DA is observed (Figure 5B), correspond-
ing to Ca21-dependent neurotransmitter release from a-Syn Modulates Paired Stimulus Depression
of DA Releasesmall synaptic vesicles (Wightman and Zimmerman,
1990), which is abolished in the presence of 200 mM Dynamic changes in DA release are thought to underlie
the physiological functions of DA pathways, such as thecadmium (data not shown). The peak DA level is a func-
tion of competing mechanisms of synaptic release and learning and execution of motor tasks and the recogni-
tion of novelty and reward (Rebec et al., 1997). For in-reuptake, whereas the time course of the subsequent
DA decrement reflects the rates of DA reuptake and stance, stimulation-dependent DA release is depressed
in the nucleus accumbens during the establishment ofdiffusion.
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Figure 2. Expression of the Synuclein Family
in the CNS
(A±C) Coronal brain sections from wt and
a-Syn2/2 mice were analyzed by in situ hybrid-
ization with antisense RNA probes for a-Syn
(A), b-Syn (B), and g-Syn (C). In wt mice, high
levels of a-Syn expression were observed in
the cerebral cortex (ctx), hippocampus (hip),
substantia nigra pars compacta (snc), and
ventral tegmental area (vta). a-Syn expres-
sion was not detected in homozygous mu-
tants. b-Syn expression was widespread (see
text) in both genotypes. g-Syn expression ap-
peared most prominent in the VTA and SNC.
(D) Immunohistochemical analysis of a-Syn
protein in the striatum.
Abbreviations: gn, geniculate body; cg, cen-
tral gray; pn, pontine nuclei; ip, interpeduncu-
lar nucleus; ter, presynaptic terminal; and
neu, neuron. Scale bar, 1 mm (A±C) and 37
mM (D).
intracranial self-stimulating behavior, a model of learn- intervals of ,60 s (Figures 5D and 5E). We designated
this phenomenon paired stimulus depression (PSD). Ining and reward (Garris et al., 1999). Consistent with the
nature of DA neurotransmission in vivo, DA release from contrast, when striatal slices from a-Syn2/2 mice were
exposed to the same paired electrical stimuli, the recov-striatal slice preparations, as evoked by pairs of electri-
cal stimuli, exhibits depression and recovery that are ery of DA release was significantly faster (p , 0.01 for
5, 10, 20, and 30 s time intervals, two-way ANOVA fordependent in part on DA autoreceptors (Starke et al.,
1989; Kennedy et al., 1992; Garris et al., 1999). We repeated measures with subsequent Newman-Keuls
test; Figures 5D and 5E). As reported for rat nigrostriatalsought to examine whether a-Syn plays a role in activity-
induced modulation of synaptic DA release. terminals (Kennedy et al., 1992), the time course for
synaptic recovery is well described by a double expo-Striatal brain slices (containing DA terminals from the
nigrostriatal pathway) were electrically stimulated with nential function (Figure 5E). In wt animals, the time con-
stants for the slow component, ts, and the fast compo-paired pulses (1 ms, 400 mA) at interpulse intervals rang-
ing from 2.5 to 60 s (Figure 5D), and peak extracellular nent, tf, were 24 s and 6 s, respectively (n 5 20 slices
from 12 animals). In contrast, the time constants forDA levels in response to each stimulus were measured
using CV. In slices from wt mice, peak DA levels follow- recovery of peak DA levels at a-Syn2/2 terminals were
16 s for ts and 5 s for tf (n 5 24 slices from 14 animals).ing the second stimulus were reduced as compared with
the peak levels following the first stimulus for interpulse Unlike their wt siblings, all the of a-Syn2/2 129SV/j 3
Nigrostriatal Deficits in a-Synuclein Mutant Mice
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Figure 3. Morphology of the Nigrostriatal
Pathway in wt and a-Syn2/2 Mice
(A) In situ hybridization of coronal brain sec-
tions with a probe for TH, the rate-limiting
enzyme in DA synthesis.
(B±E) Staining of coronal sections through the
SN (B) and the striatum (C±E) with antibodies
for TH (B and C), neuropeptide Y (D), or cal-
bindin (E). No deficits or abnormalities in neu-
ronal number, morphology, or innervation
pattern are observed in the a-Syn2/2 mice.
Abbreviations: patch, striatal matrix patch,
and neu, neuron. Scale bar, 1 mm (A); 104
mm (B); 44 mm (C); 147 mm (D); and 139 mm (E).
C57/BL6 F2 mice are homozygous for an a-Syn locus have identified and analyzed 129SV/j 3 C57/BL6 F2 mice
that are homozygous for the wt 129SV/j-derived a-Synthat is derived from the 129SV/j origin. Thus, it remained
possible that the observed deficits are due to a gene locus (see Experimental Procedures). These mice (n 5
5) displayed PSD with a time course identical to thatthat is linked to the 129SV/j-derived a-Syn and not to
the a-Syn deficiency. To exclude this possibility, we observed for the wt littermates of the a-Syn2/2. Taken
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Figure 4. Expression of Presynaptic Termi-
nal Proteins in wt and a-Syn2/2 Mice
(A±C) Coronal slices of the striatum were
stained for the vesicular release proteins syn-
aptophysin (A) and Rab3a (B), as well as for
b-Syn (C). These proteins are all expressed at
vesicular release sites, and their expression
appears normal in the a-Syn2/2 mice.
(D) Electron micrographs of synaptic termi-
nals in the striatum. The morphology and dis-
tribution of synaptic boutons and neurotrans-
mitter vesicles appeared unaltered in a-Syn2/2
mice.
Abbreviations: psd, postsynaptic density; sv,
synaptic vesicles; den, dendrite; sc, synaptic
cleft; and pdp, presynaptic dense projec-
tions. Scale bar, 29 mm (A); 22 mm (B); 26 mm
(C); and 0.2 mm (D).
together, these findings strongly support the idea that represents multiple, temporally overlapping DA release
events (see Experimental Procedures). As was the casea-Syn deficiency accelerates the recovery of DA release
following an initial stimulus and suggest an inhibitory with paired single stimuli, the initial train stimulus led to
inhibition of peak DA release to the second train stimulusrole for this protein in the activity-dependent modulation
of DA neurotransmission. (Figure 6B). However, in wt animals, the recovery of the
peak DA response following train stimulation (n 5 11To further define the scope of the alteration in DA
neurotransmission, we next investigated DA release in slices from 9 animals) was considerably faster than the
recovery following a single pulse (p , 0.01 for 2.5, 5,response to other stimulation patterns. Specifically, we
examined the recovery of DA release for pairs of burst- 10, 20, and 30 s time intervals, two-way ANOVA for
repeated measures with subsequent Newman-Keulslike stimuli since the observed firing frequency of nigral
DA neurons in vivo displays both single action potential test; Figure 6B). In contrast, in striatal preparations from
a-Syn2/2 mice, the time course of recovery from trainspikes and bursts of firing (consisting of three to ten
spikes at 10±20 Hz (Grace and Bunney, 1984). Striatal stimulation was only mildly hastened in comparison with
single pulse stimulation (p , 0.01 for the 5 s interval, two-slice preparations were presented with pairs of 10 pulse,
20 Hz stimulation trains at interburst intervals of 2.5±60 way ANOVA for repeated measures with subsequent
Newman-Keuls test; n 5 10 slices from 7 animals; Fig-s (Figure 6A), and the peak level of extracellular DA that
was released with each train was measured. This peak ures 6C and 6E). Furthermore, the recovery from train
Nigrostriatal Deficits in a-Synuclein Mutant Mice
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Figure 5. a-Syn2/2 Mice Exhibit Altered PSD of DA Release
Electrically evoked DA release in striatal slice preparations was
measured using carbon-fiber electrodes and fast-scan CV.
(A) Background-subtracted voltammograms depicting measured
DA concentration following exposure to 5 mM DA and following 1
pulse stimulation of a striatal slice. DA is identified by virtue of
the characteristic oxidation (dashed line) and reduction currents in
response to applied voltage wave.
(B) A representative time course of measured DA concentration
(scan at 10 Hz) in response to a single electrical pulse (400 mA, 1
ms; schematic at bottom); a rapid rise in DA is observed, followed
by a gradual decline.
(C) The peak DA response to either a single pulse (wt, n 5 12 slices;
a-Syn2/2, n 5 14 slices) or a train stimulus (10 pulses delivered at Figure 6. The Alteration in DA Release in the a-Syn2/2 Mice Is De-
20 Hz; wt, n 5 6; a-Syn2/2, n 5 10) did not differ significantly between pendent on the Mode of Stimulation and the Bath Divalent Ion Com-
genotypes. In response to a train of 10 pulses at 20 Hz, the measured position
DA peak represented multiple, temporally overlapping DA release (A) Striatal slices were presented with a pulse pair, as depicted
events, and therefore, the response to such train stimulation was schematically in Figure 5D (inset), or with pairs of 10 pulse, 20 Hz
significantly greater than to single pulses, regardless of the ge- stimulation trains at variable interstimulus intervals, as depicted.
notype. (B and C) DA synapses from wt (B) and a-Syn2/2 (C) mice differ
(D) Paired pulse depression is altered in a-Syn2/2 slices. Paired significantly in their ability to recover from single pulse depression,
electrical stimuli were applied at variable interpulse intervals (inset) as in Figure 5E. However, synaptic recovery from a stimulus train
to slice preparations from wt and a-Syn2/2 mice. Representative is similar in the two genotypes (wt, n 5 11 slices from 9 animals;
recording traces from wt (thin trace) and from a-Syn2/2 mutant slices a-Syn2/2, n 5 10 slices from 7 animals).
(bold trace; offset for presentation, normalized in amplitude to the (D) The nature of the stimulation protocol had a more profound
first peak of the wt recordings) are shown. Synaptic release recov- effect on the time course of synaptic recovery in the wt than the
ered significantly faster in a-Syn2/2 slices than in wt slices. mutant mice. This is presented as the difference in percent depres-
(E) Averaged time courses for recovery of the peak DA response sion between the two stimulation protocols (%Dpulse-pair 2 %Dtrain-pair).
are presented as the percent depression of the second stimulus (E and F) In the presence of increased extracellular Ca21 (10 mM
response relative to the first (100 3 [1 2 s peak amplitude/first peak versus 2.4 mM), synaptic recovery from a single pulse stimulus was
amplitude]) in wt (n 5 20 slices from 16 animals) and a-Syn2/2 (n 5 24 significantly hastened in slices from wt mice ([E], 4 slices from 3
slices from 14 animals) slices. Data were fitted by double exponential animals), whereas mutant slices ([F], 10 slices from 5 animals) were
functions (solid lines) of the form [50 3 exp(2k1 3 x)] 1 [50 3 exp less affected. Moreover, the two genotypes did not differ signifi-
(2k2 3 x)]; ts, slow component time constant; tf, fast component cantly in their recovery from depression in the presence of increased
time constant. Error bars represent standard error of the mean. extracellular Ca21.
(G) The affect of increased extracellular Ca21 on synaptic recovery
was more prominent in slices from wt than from a-Syn2/2 mice. This
is presented as the difference in percent depression between thestimulation did not differ significantly between the two
two conditions (%D2.4 mM Ca21 2 %D10 mM Ca21).
genotypes (Figures 6B and 6C). Taken together, these
findings indicate that a-Syn does not regulate DA neuro-
transmission in response to pairs of burst-like stimuli.
Given the finding that electrically evoked DA release
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is altered in the a-Syn mutant mice, we also examined vesicle fusion, blockade of Ca21 channels with 200 mM
cadmium led to the elimination of DA release in wt stria-the affect of a-Syn deficiency on amphetamine-stimu-
lated DA release. DA release in response to amphet- tal slices (data not shown). In addition, DA release follow-
ing a single stimulation was potentiated (1.7-fold in wtamines differs considerably from electrically evoked ve-
sicular exocytosis in that it is Ca21 independent and mice, 1.8-fold in the a-Syn2/2 mutants) when Ca21 levels
were raised from 2.4 mM to of 10 mM. More importantly,mediated by ªreverse transportº of the plasma mem-
brane DA transporter (Sulzer et al., 1995; Fon et al., in slices from wt mice, the recovery from PSD was signifi-
cantly hastened by higher Ca21 concentrations. Thus,1997; Jones et al., 1998). Peak extracellular DA levels
evoked by 10 mM amphetamine sulfate appeared normal in the presence of 2.4 mM Ca21, the slow component
of the recovery from PSD displayed a time constant ofin a-Syn2/2 mice (wt, 1.93 6 0.43 mM, n 5 5; a-Syn2/2,
2.16 6 0.49 mM, n 5 7), indicating that amphetamine- ts 5 24 s, and the fast component a time constant of
tf 5 6.5 s (n 5 4 slices from 3 animals). In contrast, inregulated DA release and reuptake do not require the
presence of a-Syn. the presence of 10 mM Ca21, ts was 18 s and tf was 2.5
s (Figure 6E). Surprisingly, PSD was less affected by
elevated Ca21 in slices from the mutant mice. Thus,a-Syn Does Not Change PSD through a D2
a-Syn2/2 striatal slices displayed a ts of 18 s and tf ofAutoreceptor Pathway
5.5 s with 2.5 mM Ca21, and a ts of 17 s and tf of 3.0 sThe mechanism by which recent past stimuli depress
in the presence of 10 mM Ca21 (n 5 10 slices from 5subsequent DA neurotransmission is not well under-
animals; Figures 6F and 6G). Taken together, these re-stood. However, DA D2 autoreceptors, which are pres-
sults suggest that a-Syn and extracellular Ca21 regulateent on the presynaptic membrane, have been impli-
PSD recovery by similar mechanisms and are consistentcated. Activation of DA D2 autoreceptors can lead to a
with the notion that PSD is a consequence of the deple-decrease in subsequent DA release, whereas D2 antago-
tion of a RRP of synaptic vesicles.nists appear to accelerate the time course of synaptic
recovery (Kennedy et al., 1992). To investigate whether the
observed differences in PSD between wt and a-Syn2/2 a-Syn Is Not Essential for Long-Term Potentiation
of Glutamatergic Synapses in the Hippocampusmice might be due to a difference in autoreceptor activ-
ity, we repeated the above experiments in the presence As a-Syn expression is prominent in the adult hippocam-
pus (Figure 2A), we next investigated whether mutantof the D2 receptor antagonist sulpiride. The PSD recov-
ery time and magnitude of peak DA release following a animals display altered synaptic modulation in this re-
gion. Tissue slices were prepared from the hippocam-single stimulus were unaltered by sulpiride, regardless
of the genotype (n 5 4 for both genotypes), indicating pus of wt and a-Syn2/2 mice, and long-term potentiation
(LTP) of excitatory synapses in the CA1 region of thethat autoreceptor activation does not modulate PSD for
single stimuli. In contrast, as previously noted (Kennedy hippocampus was elicited by tetanic electrical stimula-
tion at 100 Hz for 1 s, repeated four times every 20et al., 1992), sulpiride appeared to potentiate the peak
level of DA release in response to a single 10 pulse s (Castillo et al., 1997; SchluÈ ter et al., 1999). Robust
N-methyl-D-aspartate receptor±dependent LTP was ob-stimulus train (z130%; data not shown). Moreover, in
both genotypes, sulpiride significantly accelerated the served in both wt and a-Syn2/2 mice (Figure 7A). Simi-
larly, the Syn2/2 excitatory mossy fiber output from thetime course for PSD recovery of peak DA release follow-
ing train stimulation (wt with sulpiride, ts 5 5.5 s; wt dentate granule cells to the pyramidal cells in the CA3
region of the hippocampus displayed normal mossy fi-without sulpiride, ts 5 12.5 s, n 5 3; a-Syn2/2 with sulpir-
ide, ts 5 4.5 s; a-Syn2/2 without sulpiride, ts 5 11 s, n 5 ber LTP (Figure 7A), a presynaptic form of glutamatergic
plasticity (Tong et al., 1996). Thus, a-Syn does not ap-4). Taken together, these data indicate that recovery
from train stimulation, but not from a single stimulus, is pear to be required for these forms of glutamatergic
synaptic modulation.attenuated by the DA D2 autoreceptor and that a-Syn
inhibits synaptic recovery by a mechanism independent
of the D2 autoreceptors. DA Content Is Reduced in Mutant Mice
Given the alteration in DA release, we next examined
whether the absence of a-Syn leads to a change inThe Effects of a-Syn Can Be Simulated by Ca21
Short-term depression (with a decay time constant of striatal DA content, the bulk of which is stored in synap-
tic vesicles (Fon et al., 1997; Jones et al., 1998). Quantifi-5±30 s) at certain CNS synapses has been interpreted
as the depletion of a limited pool of readily releasable cation by reverse-phase high-pressure liquid chroma-
tography (HPLC) in tissue punch biopsies revealed thatsynaptic vesicles (RRP; Dittman and Regehr, 1998; Ste-
vens and Wesseling, 1998; Wang and Kaczmarek, 1998; DA content was significantly reduced in the striatum of
a-Syn2/2 mice, as compared with wt mice (18% reduc-Gomis et al., 1999). According to this model, once the
RRP is emptied by an initial stimulus, the response to tion, Student's t test, p 5 0.004; Figure 7B). DA content in
the ventral midbrain (SN1 VTA) and nucleus accumbenssubsequent stimulation depends on the size and rate
of refilling of this pool. Furthermore, refilling of the RRP was comparable in the two genotypes (data not shown).
Additionally, we measured the striatal content of theappears to be accelerated by high-frequency stimula-
tion or increased extracellular Ca21. Given the similar major DA metabolite 3,4-dihydroxyphenylacetic acid
(DOPAC). The ratio of DOPAC:DA is thought to reflect thetime course and activity dependence of PSD that we
observe, we investigated whether recovery from PSD in relative rate of DA degradation (turnover or utilization;
Horger et al., 1998). We found that the absolute concen-striatal slices is Ca21 dependent.
As expected, given the involvement of Ca21 in synaptic tration of striatal DOPAC was comparable in the two
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Figure 7. a-Syn2/2 Mice Display Normal LTP but Reduced Striatal DA Content and Decreased Sensitivity to Amphetamine-Stimulated Loco-
motion
(A) LTP appears unaltered at the hippocampal mossy fiber±CA3 and Schaffer collateral±CA1 synapses of a-Syn2/2 mice. Induction of LTP by
tetanic stimulation (at Time 5 0; see Experimental Procedures) is observed in hippocampal slices from wt (n 5 5) and a-Syn2/2 (n 5 5) mice.
(B) Striatal DA and DOPAC contents were measured in brain punch biopsies from wt and a-Syn2/2 mice. a-Syn2/2 mice (n 5 9) displayed
significantly reduced striatal DA content (18%, Student's t test, p 5 0.004) in comparison with wt controls (n 5 10). Striatal DOPAC content
and the DOPAC:DA ratio did not differ significantly among the genotypes.
(C and D) a-Syn2/2 (n 5 12) and wt (n 5 19) mice exhibited similar patterns of activity in the context of a novel environment. Mice were placed
in a 38 3 45 cm Plexiglas arena, and locomotion was assessed for 2 hr by the number of times photocell beams were crossed per 10 min
interval. An intraperitoneal saline injection was given during the fourth interval (arrow, [C]). wt (n 5 19) and homozygous mutant (n 5 11) mice
both demonstrated an increase in locomotion after an intraperitoneal injection of D-amphetamine (4 mg/kg body weight). However, homozygous
mutants displayed a significantly attenuated amphetamine response (repeated measures ANOVA: p 5 0.016 for genotype).
genotypes (Figure 7B). Furthermore, the DOPAC:DA ra- the novel environment over time (n 5 19 wt and n 5 12
mutant mice; repeated measures ANOVA: p 5 0.34 fortio was not significantly altered in the mutants, although
a trend was noted for higher DOPAC:DA ratios in the genotype 3 time interaction, p , 0.0001 for time; Figures
7C and 7D). Thus, a-Syn is not required for the locomotorstriatum of a-Syn2/2 mice (Student's t test, p 5 0.12;
Figure 7B). These data suggest that the reduced DA response to novelty.
content in the a-Syn2/2 mice results from decreased DA
synthesis or storage. The deficit may reflect either a Amphetamine-Stimulated Locomotion Is Reduced
direct effect of a-Syn deficiency or a compensation for in the a-Syn2/2 Mice
the altered dynamic DA release. Amphetamines can dramatically stimulate locomotor
activity by increasing DA release through multiple mech-
anisms and by inhibiting its reuptake (Seiden et al., 1993;a-Syn Deficiency Does Not Alter Locomotor
Activity in a Novel Environment Wise, 1996). Given the altered striatal DA release and
DA content in the a-Syn2/2 mice, we examined whetherModulation of DA neurotransmission is thought to un-
derlie the increased locomotor activity observed when amphetamine-mediated locomotor behavior may also
be modified. Although amphetamine-regulated DA re-an animal is placed in a novel environment (Rebec et al.,
1997; Garris et al., 1999). Given the observed changes in lease and reuptake appear intact in brain slices from
mutant animals (see above), we anticipated that theDA neurotransmission and DA content, we sought to
determine whether a-Syn2/2 mice might display altered a-Syn2/2 mice may still display deficits in amphetamine-
mediated behaviors since such behavior reflects multi-locomotor behavior when placed in new open-field sur-
roundings. Spontaneous locomotor activity was mea- ple presynaptic and postsynaptic functions.
We investigated the locomotor response of mutantsured over 2 hr by means of a photocell grid counter.
wt and a-Syn2/2 mice did not differ significantly in this (n 5 12) and wt (n 5 19) mice to an intraperitoneal
injection of D-amphetamine (4 mg/kg). As mentioned,task and displayed a similar pattern of habituation to
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spontaneous locomotor activity prior to the injection of involve GABA, glutamate, or acetylcholine were not
D-amphetamine did not differ between the genotypes found to play a role in PSD in the DA system (Kennedy
(Figures 7C and 7D). Subsequent to the amphetamine et al., 1992). However, we have not excluded an inhibi-
injection, both wt and mutant animals exhibited in- tory role for a-Syn through other yet unidentified presyn-
creased locomotion, indicating that a-Syn is not essen- aptic receptors.
tial for the basic response to amphetamine. However, Alternatively, a-Syn may modify PSD by modulating
a-Syn2/2 mice displayed a significantly attenuated re- the replenishment of synaptic vesicles at DA synapses.
sponse to D-amphetamine, as compared with wt mice Forms of short-term depression similar to PSD have
(repeated measures ANOVA: p 5 0.0158 for genotype; been described at other CNS synapses (Stevens and
Figures 7C and 7D). Given the observation that amphet- Tsujimoto, 1995; Wang and Kaczmarek, 1998). To ex-
amine-regulated DA release and reuptake appear nor- plain these observations, it has been hypothesized that
mal in the mutants, the decreased locomotor response a limited RRP of synaptic vesicles is present at each
to amphetamines in a-Syn2/2 mice likely represents a synapse and that once this pool is depleted, subsequent
compensatory postsynaptic change secondary to the synaptic responses are depressed. Thus, restrictions on
observed disinhibited vesicular release. the size and replenishment rate of the RRP may limit
the release capacity of presynaptic terminals, and short-
Discussion term forms of synaptic depression may represent the
time course necessary for regeneration of the RRP
Our analysis of a-Syn-deficient mice indicated that they (Goda and SuÈ dhof, 1997). By analogy, PSD at nigrostria-
are viable, fertile, and do not display any gross patholog- tal synapses may reflect the time necessary to refill a
ical abnormalities. The CNS of a-Syn2/2 mice appears depleted RRP of DA after a prior stimulus. The apparent
morphologically intact and possesses a wt complement Ca21 dependence of PSD, combined with the finding
of DA neurons and nerve terminals. Despite the lack that train stimulation accelerated the recovery of DA
of any morphological abnormalities, the a-Syn2/2 mice release at nigrostriatal terminals, provides support for
suffer significant neurochemical, electrophysiological, this analogy. Thus, a-Syn may negatively regulate DA
and behavioral deficits. They exhibit faster recovery release in part by modulating the refilling rate of the
from PSD and display a reduction in total striatal DA RRP. The normal morphology of synaptic terminals and
levels, as well as an attenuated locomotor response to vesicles in the a-Syn2/2 mice and the physical presence
amphetamine. These findings are most consistent with of a-Syn in the direct vicinity of synaptic vesicles (Iwai,
the idea that a-Syn is an essential, activity-dependent 1995) are consistent with such a regulatory rather than
negative regulator of DA neurotransmission.
structural role. Of note, the two mechanistic models of
PSD described above are not mutually exclusive. That
Regulation of DA Release Is Altered is, autoreceptor inhibition may alter the size or refilling
in the Mutant Mice rate of the RRP of synaptic vesicles.
a-Syn2/2 mice are defective in a form of synaptic depres-
A possible molecular mechanism by which a-Syn
sion normally exhibited at nigrostriatal terminals that we
might regulate vesicular release is suggested by the
term PSD. Specifically, we find that the recovery of peak
observation that it is a specific, potent (Ki 5 10 nM)DA release after an initial stimulus is 35% more rapid in
inhibitor of PLD2 (Jenco et al., 1998). PLD2 catalyzes
a-Syn2/2 mice, as compared with wt littermates. Stimula-
the hydrolysis of phosphotidylcholine to form PA andtion-dependent DA release is depressed in the nucleus
DAG (Klein et al., 1995; Jenco et al., 1998), both of whichaccumbens during the establishment of intracranial self-
are intracellular mediators that modulate neurotransmit-stimulation behavior (Garris et al., 1999), a model of
ter release. DAG is believed to potentiate neurotransmit-learning and reward. Similarly, activity-dependent regu-
ter release by increasing the size and recovery rate oflation of DA release had been suggested to underlie the
the RRP through the activation of protein kinase C,execution of motor tasks and working memory (Williams
whereas PA has been shown to stimulate vesicle forma-and Goldman-Rakic, 1995).
tion (Frohman and Morris, 1996). Thus, a-Syn may nega-The mechanism of plasticity at DA synapses is poorly
tively regulate DA release in part by inhibiting the forma-understood. In this study, we provide evidence that a-Syn
tion of DAG and PA by PLD. As a-Syn may interactregulates one form of DA plasticity, PSD. We investi-
directly with protein kinase C (Ostrerova et al., 1999)gated two potential mechanisms of a-Syn action in PSD:
and contains multiple potential phosphorylation sitesmodulation of autoreceptor-dependent presynaptic in-
for this kinase, it may in turn be (positively or negatively)hibition of neurotransmitter release and regulation of the
regulated by protein kinase C as part of a feedbackRRP of synaptic vesicles. In the DA system, autorecep-
pathway. Alternatively, since functional regeneration oftor-dependent presynaptic inhibition is largely mediated
RRP requires Ca21, a-Syn may regulate DA neurotrans-by the DA D2 receptor (through the inactivation of volt-
mission by modulating the levels of intracellular Ca21 orage-dependent Ca21 currents; Kennedy et al., 1992).
the activity of Ca21-dependent proteins. It is interestingWe find that the D2 antagonist sulpiride reduced PSD
to note that although a-Syn is prominently expressedfollowing train stimulation (train PSD) but did not change
in the hippocampus, no deficit in hippocampal LTP wasthe time course of synaptic recovery after a single pulse
observed. The normal LTP may reflect compensation(single pulse PSD). In contrast, a-Syn deficiency im-
by b-Syn that is also expressed in this brain region.paired single pulse PSD but not train PSD. These findings
Alternatively, a-Syn may play a role in PSD but not inargue that a-Syn influences PSD via a DA D2 receptor±
independent mechanism. Other inhibitory mechanisms that other forms of synaptic plasticity.
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a-Syn-Deficient Mice Exhibit Decreased Striatal represents a potential therapeutic target for PD as well
as other movement and psychiatric disorders. Disrup-DA Content and Amphetamine Sensitivity
The a-Syn2/2 mice exhibited significantly reduced levels tion of the synthesis, function, or, possibly, the aggrega-
tion of a-Syn would be predicted to increase DA releaseof total striatal DA, which is primarily stored in synaptic
vesicles (Fon et al., 1997). The reduced total striatal DA from the surviving nigral DA neurons and may slow the
progression of PD without serious deleterious effects.level in the mutants is not due to a deficit in the density
of nigrostriatal DA projections or altered DA reuptake.
Instead, consistent with the idea that a-Syn is a negative
Experimental Proceduresregulator of RRP, it may reflect an enhanced rate of
vesicular trafficking to the RRP and subsequent release. Generation of a-Syn2/2 Mice
The a-Syn2/2 mice also display an attenuated locomotor Murine a-Syn cDNA was amplified from total brain cDNA using
a-Syn-specific primers (59-AATACATCTTTAGCCATGGA-39 andresponse to amphetamine. This deficit may represent a
59-TCACCCTTGCCCATCTGGTCCTT-39). A 129SV/j mouse genomicdownstream adaptation (desensitization) to the altered
lFixII phage library (Stratagene) was screened with this cDNA topattern of DA neurotransmission or may be a conse-
obtain a 14.5 kb NotI genomic fragment encompassing the firstquence of the reduced DA content in these animals.
three exons of the a-Syn gene (encoding amino acids 1±41) and
flanking sequences which was subcloned into pBluescriptII (Stra-
tagene). This plasmid was then digested with KpnI to excise a 1.5a-Syn Function in Neurodegenerative Disease
kb KpnI genomic fragment. The resulting plasmid was digested witha-Syn has been implicated in the pathophysiology of
EcoRI and XhoI to excise a 3.2 Kb genomic region encompassingneurodegenerative disorders, including PD and AD, but
the first three exons of the a-Syn gene, which was replaced with a 1.6it remains unclear whether the involvement of this pro-
Kb MfeI±SalI fragment of plasmid pGT-N39 (New England Biolabs)
tein in neurodegeneration is at all related to its normal containing the PGK-neo cassette. The resulting targeting vector was
function. A widely held view is that the single amino linearized with KpnI and electroporated into ES GS cells, which were
selected in G418 (400 mg/ml). To identify homologous integrationacid substitutions underlying dominantly inherited PD
events, BglI-digested genomic DNA isolated from neomycin-resis-represent neomorphic mutations and lead to a novel
tant clones was hybridized to a KpnI fragment flanking the 39 termi-pathological gain of function for this protein. Specifi-
nus of the targeting vector. Three clones with homologous recombi-cally, it has been hypothesized that mutant a-Syn medi-
nation were identified among 200 G418-resistant clones. Chimeric
ates neuronal degeneration because of a tendency to male mice were generated, and these mice were bred to C57/BL6
aggregate and to form toxic inclusion bodies. Abnormal females to confirm germline transmission. Following heterozygous
mating, progeny were genotyped by Southern blotting, as describedprotein aggregates have been described in a number of
above, or by PCR analysis with primers specific for exon 2 ofother neurodegenerative diseases, including tau protein
a-Syn (59-ATGGATGTGTTCATGAA-AGGACTTTCAA-39 [designatedaggregates in frontotemporal dementia (Hong et al.,
as ªaº in Figure 1]; 59-TACATAGAGGACTCCCT-CTTTTGTCT-391998), huntingtin protein aggregates in Huntington's dis-
[designated as ªbº in Figure 1]) and the neomycin resistance gene
ease (DiFiglia et al., 1997), and prion protein aggregates (59-AGGCGATAGAAG-GCGATGCG-39 [designated as ªcº in Figure
in Creutzfeld-Jacob disease (Cohen and Prusiner, 1998). 1]; 59-CAAGACCGACCTGTCCGGTG-39 [designated as ªdº in Figure
1]). To confirm the absence of a-Syn expression in mutant mice,An alternative hypothesis is that human a-Syn muta-
RT-PCR and Western analyses were performed on brain sections.tions might function in a dominant-negative manner and
For RT-PCR analysis, total RNA was isolated from 100 mg cerebralthat the inherited disease state might therefore be due
cortex sections using RNAzol (Tel-Test), and cDNA was generatedto a decrement in the normal function of a-Syn. The
from 5 mg of total RNA. PCR was performed with primers specific
fact that a-Syn can dimerize with itself and with other for the 59 terminus (encoding amino acids 1±92; 59-AGCCATGGATG
members of this protein family lends support to the TGTTCAT-GAAAGG-39 and 59-GTGGCAGCAGCTA-TATTCCCAG
CT-39) or the 39 terminus (encoding amino acids 76±136; 59-GCAdominant-negative hypothesis. Of particular interest in
GTCGCTC-AGAAGACAGTGGA-39 and 59-AGTCTTG-TAG-CTTCT-this regard is g-Syn, which is selectively expressed in
CTGAAG-39). For Western analysis, tissue sections were homoge-DA neurons of the ventral midbrain and may physically
nized in lysis buffer (1% NP-40, 50 mM Tris-Cl [pH 8.0], 150 mMinteract with a-Syn through a shared putative hetero-
NaCl, 1 mM phenylmethylsulfonyl fluoride, and 10 mM leupeptin),
dimerization domain. The mild phenotype that the and immunoblot analyses were performed as described using rabbit
a-Syn2/2 mice display argues against the hypothesis that polyclonal antibodies specific to the carboxyl termini of a-Syn or
b-Syn (Chemicon). 129SV/j 3 C57/BL6 F2 mice that are wt at thethe PD a-Syn mutations lead to dominant inactivation
a-Syn locus were selected for the 129SV/j allele by PCR analysisof this protein. However, as kindreds that suffer from
of a polymorphism within the second intron using the primer pairthe human disease remain relatively unaffected for the
(59- ACCAGGAGTTGATGGTCATCTTCAGCT-39 and 59-AAGTC-CCAfirst three decades of life, it is possible that older a-Syn
TGAGTACTTGTGGCTCACT-39).
mutant mice would suffer DA neuron loss or that the
pathology requires a premorbid period that is longer
In Situ Hybridizationthan the life span of a mouse. Alternatively, dominant-
Brains from wt and a-Syn2/2 mice (n 5 3 each) were fresh frozennegative forms of a-Syn may lead to a severe phenotype
with powdered dry ice, and 16 mm coronal sections were cut on a
that is not mimicked by a-Syn deficiency through the cryostat. 33P-UTP-labeled RNA probes were synthesized from DNA
formation of inactive heterodimers with other members templates using T7 polymerase. DNA templates were generated
by PCR amplification of mouse total brain cDNA with primer pairsof the Syn protein family, such as g-Syn. Finally, since
specific for a-Syn (59-GGATCCAGCAAAGATACATCTTTAGCC-39one of the pathological mutations in the human a-Syn,
and 59-GAATTCTAATACGA-CTCACTATAGGGATTCTTAGGCTTA53T, is normally present in wt mice, it is possible that
CAG-39), b-Syn (59-GGATCCCCCCGAAA-CCCAGGCCGCCAG-39species differences or developmental compensation by
and 59-GAATTCTAATACGACTCACTATAGGGCCTGATATTCCTCC
the other synuclein family members may be responsible TGGGGTG-39), g-Syn (CAATGAATTCTAATACGACTCACTATAGGG
for the mild mouse phenotype. GGACAGAGAACTTGGGCAACCTGC-39 and 59-CAATGGATCCAAT-
TAACCCTCACTAAAGGGAAGGAGAA-CGTGGTACAAAGTGTCAC-39),As a-Syn functions in the regulation of DA release, it
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or TH (Hynes et al., 1995). Template identities were confirmed by and acquired with a locally written Superscope II program (GWI).
DA release was evoked by a bipolar stimulating electrode placedDNA sequencing. Autoradiographic exposure times were 3 weeks.
at a 100±150 mm distance from the recording electrode with either
single pulse (400 mA, 1 ms) stimulation or a train of 10 pulses at 20Immunohistochemistry
Hz. Background-subtracted cyclic voltammograms served to iden-For histological analysis, adult mice were anesthetized with Nembu-
tify the released substance, which was DA in every case reported.tal and perfused transcardially with 4% paraformaldehyde in 0.1 M
Two-sample Student's t test or two-way ANOVA for repeated mea-phosphate buffer (PB) with or without 0.5% glutaraldehyde. Brains
sures with subsequent Newman-Keuls test were used for statisticalwere dissected out and washed in PB, and 50 mm thick sections
analysis (GB-Stat). Double exponential fitting was performed withwere obtained in a vibrotome. Sections were incubated in 3% H2O2
Igor software (Wavemetrics). CA1 LTP was elicited by tetanic stimu-to quench endogenous peroxidase activity and then blocked for 1
lation (trains of 100 pulses at 100 Hz, repeated four times at 20 shr in 10% normal goat serum and 0.2% Triton X-100 in PB. Subse-
intervals) and recorded in the presence of 10 mM bicuculline at aquently, sections were incubated overnight with one of the following
basal stimulation rate of 0.05 Hz (Castillo et al., 1997; SchluÈ ter etprimary antibodies (dilutions in parentheses): anti-parvalbumin
al., 1999). Mossy fiber LTP was induced by tetanic stimulation (trains(Swant, Switzerland, 1:8,000), anti-calbindin (Swant, Switzerland,
of 125 pulses at 25 Hz, repeated once after a 20 s interval) and1:10,000), anti-neuropeptide Y (Incstar, 1:15,000), anti-calretinin
recorded in the presence of 40 mM D-APV (Castillo et al., 1997).(Swant, Switzerland, 1:10,000), anti-somatostatin (Incstar, 1:500),
anti-a-Syn (Chemicon, 1:1,000; Santa Cruz C-20, 1:100), anti-b-Syn
Quantification of DA and DOPAC(Chemicon, 1:1,000), anti-synapsin-I (Synaptic Systems, 1:100), anti-
Nine a-Syn2/2 and ten wt mice were analyzed for postmortem tissueRab3a (Synaptic Systems, 1:500), or anti-synaptophysin (Boehringer
content of DA and DOPAC. After cervical dislocation, the brain wasMannheim, 1:25). Sections were then processed using the ABC per-
removed, immersed in ice-cold PBS for 30 s, placed in a mouseoxidase method (Vector Labs) following the manufacturer's instruc-
brain coronal matrix on ice (ASI Instruments, Warren, MI), and cuttions. For DA neuron counts in the SN, serial vibrotome sections
into 1 mm sections. Biopsy punches were used to collect the stria-through the midbrain were prepared as above and stained with anti-
tum (from two sections per brain, 13 gauge (13G) anterior and 11GTH antibodies (Pel-Freez, 1:300). Immunoreactive neurons with a
posterior), nucleus accumbens (from one section per brain, 16G),visible, well-defined nucleus were counted in alternate sections
and ventral midbrain (containing the SN and VTA; from two sectionsthroughout the SN.
per brain, 11G). Brain samples were sonicated in 200 ml of 0.1 M
perchloric acid with 0.005% EDTA and 3,4-dihydroxybenzylamineElectron Microscopy
(DHBA) as an internal standard and centrifuged at 23,000±28,000 3For electron microscopy, adult mice were anesthetized with Nembu-
g for 20 min at 48C. The sample pellet was sonicated in 150±1000tal and perfused with 4% paraformaldehyde and 2.5% glutaralde-
ml 0.5 N NaOH, and protein content was determined with the Bio-hyde in PB. Brains were dissected out and sectioned coronally at
Rad protein assay (Hercules, CA). DA and DOPAC in the supernatant200 mm with a vibrotome. Sections were postfixed in 2% osmium
were quantified by reverse-phase HPLC with electrochemical detec-tetroxide in PB, dehydrated in ascending grades of ethanol, stained
tion, essentially as described previously (Moore et al., 1996). Sam-in block with 2% uranyl acetate, and then flat embedded in Araldite
ples were injected onto a MetaSil octadecyl silica 3 mm (100 3 4.6(Durcupan). Selected areas were sectioned into 1 mm semithin sec-
mm) column (MetaChem Technologies, Torrance, CA) perfused withtions and stained with toluidine blue for light microscope analysis.
MD-TM mobile phase (ESA, Chelmsford, MA) at 1 ml/min. An ESAUltrathin sections containing the striatum (70 nm) were collected in
Coulochem II electrochemical detector applied 260 mV to electrodeslot grids coated with Formvar film, stained with lead citrate, and
1 and 1200 mV to electrode 2 of a coulometric analytical cell (ESA,observed with a Phillips CM-10 electron microscope. Electron mi-
model 5011). Data were acquired and peak areas calculated with
crographs of random regions of the striatum were generated from
EZChrom Chromatography Data Systems software (Scientific Soft-
at least three different animals per genotype, and synapses were
ware, Pleasanton, CA).
counted. Axon terminals with a visible synaptic contact were drawn
and measured using the Visilog software package.
Locomotor Activity Assays
Mice (49±83 days old; eight female wt, eleven male wt, four female
Electrophysiology a-Syn2/2, and eight male a-Syn2/2) were tested for spontaneous
Electrical stimulation of striatal slice preparations induces extrasyn- activity and, 1±6 days later, for amphetamine-induced activity. Total
aptic DA overflow, termed ªsynaptic overflow,º due to the synchro- photocell beam breaks per 10 min interval were collected for 2 hr
nized firing of numerous DA terminals (Garris et al., 1994). Such in a 38 3 45 cm Plexiglas arena with an 8 3 8 photocell beam grid
overflow can be measured at a high temporal and spatial resolution (San Diego Instruments). During the first half of the fourth interval,
in striatal slice preparations using carbon-fiber electrodes and fast- mice received an intraperitoneal injection of 0.9% saline (5 ml/kg
scan CV (Wightman and Zimmerman, 1990; Kennedy et al., 1992). body weight) or 4 mg D-amphetamine sulfate/kg body weight (at 0.8
In CV, a triangular voltage wave is applied to carbon-fiber electrodes mg/ml 0.9% saline). Two-way ANOVA demonstrated no significant
(Figure 4A) every 100 ms, and the presence of DA or other catechola- differences between males and females and no interaction between
mines is deduced from the resultant oxidation current (during the gender and genotype (data not shown), so data from males and
upstroke of the voltage wave) and reduction current (during the females were analyzed together.
downstroke of the voltage wave). DA is positively identified by virtue
of the characteristic voltage dependency of its oxidation and reduc- Acknowledgments
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